ProKidney Corp. (PROK) Insider Trading Activity
NASDAQ$0.8066
Market Cap
$236.09M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
4 of 877
Rank in Industry
3 of 506
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $57M | ||
| $50M |
PROK Insider Trading Activity
PROK Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $76,254,661 | 9 | 69 |
Sells | $162,098 | 4 | 31 |
Related Transactions
| Legorreta Pablo G. | 1 | $54.74M | 0 | $0 | $54.74M | |
| Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 8 | $21.52M | 0 | $0 | $21.52M |
| Weber Darin J. | Chief Regulatory Officer | 0 | $0 | 4 | $162,098 | $-162,098 |
About ProKidney Corp.
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Insider Activity of ProKidney Corp.
Over the last 12 months, insiders at ProKidney Corp. have bought $76.25M and sold $162,098 worth of ProKidney Corp. stock.
On average, over the past 5 years, insiders at ProKidney Corp. have bought $25.53M and sold $10.63M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Legorreta Pablo G. () — $54.74M. Control Empresarial de Capitales S.A. de C.V. (Add'l Rep. Persons-see Ex.99-1) — $21.52M.
The last purchase of 387,393 shares for transaction amount of $276,366 was made by Control Empresarial de Capitales S.A. de C.V. (Add'l Rep. Persons‑see Ex.99‑1) on 2025‑04‑22.
List of Insider Buy and Sell Transactions, ProKidney Corp.
| 2025-04-22 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 387,393 0.1595% | $0.71 | $276,366 | +5.59% | ||
| 2025-04-17 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 25,000 0.0108% | $0.75 | $18,690 | -0.63% | ||
| 2025-04-16 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 100,000 0.0432% | $0.75 | $74,820 | -0.84% | ||
| 2025-04-15 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 468,000 0.1881% | $0.70 | $326,009 | +11.26% | ||
| 2025-04-14 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 268,105 0.1123% | $0.73 | $194,591 | +6.65% | ||
| 2025-04-11 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 1,900 0.0007% | $0.61 | $1,155 | +7.47% | ||
| 2025-04-10 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 1.03M 0.3622% | $0.61 | $627,692 | +27.56% | ||
| 2024-09-19 | Sale | Weber Darin J. | Chief Regulatory Officer | 16,412 0.007% | $2.50 | $41,030 | -32.43% | |
| 2024-07-26 | Sale | Weber Darin J. | Chief Regulatory Officer | 826 0.0004% | $2.50 | $2,065 | -31.02% | |
| 2024-06-18 | Sale | Weber Darin J. | Chief Regulatory Officer | 17,238 0.0083% | $2.82 | $48,616 | -35.45% | |
| 2024-06-13 | Legorreta Pablo G. | 22.62M 9.3818% | $2.42 | $54.74M | -41.75% | |||
| 2024-06-11 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 8.26M 3.4281% | $2.42 | $20M | -28.10% | ||
| 2024-05-20 | Sale | Weber Darin J. | Chief Regulatory Officer | 17,238 0.0121% | $4.08 | $70,386 | -53.61% | |
| 2024-04-22 | Sale | Weber Darin J. | SVP of Regulatory Development | 16,438 0.0071% | $2.51 | $41,315 | -30.33% | |
| 2024-04-18 | Sale | Weber Darin J. | SVP of Regulatory Development | 800 0.0003% | $2.54 | $2,028 | -19.79% | |
| 2024-04-16 | Sale | Weber Darin J. | SVP of Regulatory Development | 17,238 0.0074% | $2.50 | $43,095 | -28.68% | |
| 2024-04-12 | Sale | Weber Darin J. | SVP of Regulatory Development | 84,103 0.0249% | $1.73 | $145,498 | +12.86% | |
| 2024-04-01 | Sale | Weber Darin J. | SVP of Regulatory Development | 300 <0.0001% | $1.69 | $507 | +23.13% | |
| 2024-03-25 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 30,000 0.0074% | $1.43 | $42,954 | +37.15% | ||
| 2024-03-22 | Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 14,000 0.0034% | $1.40 | $19,586 | +41.43% |
Total: 60
*Gray background shows transactions not older than one year
Insider Historical Profitability
33.75%
| Control Empresarial de Capitales S.A. de C.V. | Add'l Rep. Persons-see Ex.99-1 | 73842723 25.2283% | $59.56M | 13 | 0 | +38.33% |
| Legorreta Pablo G. | 22617909 7.7274% | $18.24M | 1 | 0 | ||
| Weber Darin J. | Chief Regulatory Officer | 103480 0.0354% | $83,466.97 | 0 | 9 | |
| Cowen Aaron | 10 percent owner | 6280175 2.1456% | $5.07M | 3 | 0 | +26.12% |
| Palihapitiya Chamath | 0 0% | $0 | 0 | 34 |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$144,247,213 | 29 | 10.15% | $255.02M | |
$56,550,550 | 22 | 50.17% | $251.53M | |
$2,484,989 | 17 | -17.86% | $221.48M | |
$1,345,573 | 16 | 15.45% | $219.08M | |
$276,750,010 | 16 | -7.95% | $244.81M | |
$3,232,510 | 15 | -2.42% | $236.31M | |
$57,263,116 | 11 | -8.37% | $242.79M | |
$58,981,940 | 10 | 32.58% | $220.53M | |
$14,995,689 | 8 | 3.76% | $245.17M | |
ProKidney Corp. (PROK) | $334,190 | 8 | 33.75% | $236.09M |
$15,297,672 | 8 | -17.63% | $266.14M | |
$214,493 | 7 | -84.84% | $241.69M | |
$94,000,000 | 7 | -20.84% | $208.76M | |
$51,588,185 | 5 | 19.18% | $223.48M | |
$79,238,118 | 4 | -26.47% | $214.68M | |
$12,010,220 | 4 | -72.15% | $227.24M | |
$4,888,000 | 3 | -20.50% | $246.93M | |
$879,499 | 1 | 28.50% | $233.76M | |
$102,796 | 1 | -21.40% | $234.49M |
PROK Institutional Investors: Active Positions
| Increased Positions | 45 | +70.31% | 2M | +3.27% |
| Decreased Positions | 26 | -40.63% | 733,455 | -1.46% |
| New Positions | 12 | New | 217,193 | New |
| Sold Out Positions | 11 | Sold Out | 219,807 | Sold Out |
| Total Postitions | 83 | +29.69% | 51M | +1.81% |
PROK Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Morgan Stanley | $11,025.00 | 10.75% | 13.97M | -297,028 | -2.08% | 2024-12-31 |
| Suvretta Capital Management, Llc | $9,737.00 | 9.49% | 12.34M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $5,337.00 | 5.2% | 6.76M | +27,650 | +0.41% | 2025-03-31 |
| Vanguard Group Inc | $4,163.00 | 4.06% | 5.28M | +60,350 | +1.16% | 2024-12-31 |
| Geode Capital Management, Llc | $1,761.00 | 1.72% | 2.23M | +27,996 | +1.27% | 2024-12-31 |
| Bleichroeder Lp | $1,578.00 | 1.54% | 2M | +155,000 | +8.4% | 2024-12-31 |
| State Street Corp | $1,371.00 | 1.34% | 1.74M | +309,546 | +21.67% | 2024-12-31 |
| Brown University | $789.00 | 0.77% | 1M | 0 | 0% | 2025-03-31 |
| Northern Trust Corp | $703.00 | 0.69% | 890,907 | +61,206 | +7.38% | 2024-12-31 |
| Hennion & Walsh Asset Management, Inc. | $666.00 | 0.65% | 844,277 | +275,630 | +48.47% | 2025-03-31 |
Financial Ratios
Summary
Comparison with Competitors
Price to Earnings
Price/Earnings to Growth
Price to Sales
Price to Book
Price/Free Cash Flow
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.